Aurinia Pharmaceuticals Inc (AUPH) Insider Trading
- $435,747.75
- $17,785,348.31
- March 7, 2025
- Michael Robert Martin
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 7, 2025 | Insider | 8,305 | $8.23 | Sell | $68,350.15 | |
| March 3, 2025 | Insider | 12,239 | $8.00 | Sell | $97,912.00 | |
| March 3, 2025 | CFO | 61,859 | $8.00 | Sell | $494,872.00 | |
| March 3, 2025 | COO | 65,902 | $8.00 | Sell | $527,216.00 | |
| March 3, 2025 | CEO | 195,593 | $8.00 | Sell | $1,564,744.00 | |
| Nov. 11, 2024 | Director | 4,557 | $8.43 | Sell | $38,415.51 | |
| Aug. 6, 2024 | Insider | 18,249 | $5.31 | Sell | $96,902.19 | |
| May 23, 2023 | Director | 8,733 | $11.26 | Sell | $98,333.58 | |
| May 19, 2023 | Director | 272 | $10.58 | Sell | $2,877.76 | |
| March 2, 2023 | Director | 20,000 | $8.91 | Buy | $178,200.00 | |
| March 2, 2023 | CFO | 11,296 | $8.94 | Sell | $100,986.24 | |
| March 2, 2023 | CEO | 32,750 | $8.94 | Sell | $292,785.00 | |
| March 2, 2023 | EVP | 19,402 | $8.94 | Sell | $173,453.88 | |
| Dec. 13, 2021 | Director | 1,600 | $20.04 | Buy | $32,064.00 | |
| Nov. 11, 2021 | Insider | 40,000 | $29.01 | Sell | $1,160,400.00 | |
| Nov. 9, 2021 | Insider | 50,000 | $30.17 | Sell | $1,508,500.00 | |
| Nov. 1, 2021 | Insider | 45,000 | $31.64 | Sell | $1,423,800.00 | |
| Oct. 25, 2021 | EVP | 130,000 | $29.75 | Sell | $3,867,500.00 | |
| Sept. 21, 2021 | EVP | 32,500 | $23.99 | Sell | $779,675.00 | |
| Sept. 21, 2021 | Insider | 87,500 | $24.02 | Sell | $2,101,750.00 | |
| Sept. 14, 2021 | Insider | 90,000 | $21.19 | Sell | $1,907,100.00 | |
| Sept. 14, 2021 | EVP | 22,500 | $21.75 | Sell | $489,375.00 | |
| Sept. 10, 2021 | EVP | 10,000 | $19.80 | Sell | $198,000.00 | |
| Sept. 10, 2021 | Insider | 25,000 | $19.80 | Sell | $495,000.00 | |
| Aug. 25, 2021 | Insider | 5,000 | $15.85 | Sell | $79,250.00 | |
| Aug. 9, 2021 | Insider | 5,000 | $16.01 | Sell | $80,050.00 | |
| July 28, 2021 | Insider | 5,000 | $13.86 | Sell | $69,300.00 | |
| June 22, 2021 | Insider | 5,000 | $13.76 | Sell | $68,800.00 | |
| May 11, 2021 | CEO | 5,125 | $10.71 | Buy | $54,888.75 | |
| May 11, 2021 | VP | 9,900 | $10.07 | Buy | $99,693.00 | |
| May 11, 2021 | CFO | 1,000 | $9.74 | Buy | $9,740.00 | |
| May 11, 2021 | Director | 2,500 | $10.96 | Buy | $27,400.00 | |
| Jan. 29, 2021 | Director | 1,200 | $16.03 | Buy | $19,236.00 | |
| Jan. 28, 2021 | EVP | 900 | $16.14 | Buy | $14,526.00 |
Insiders are both buying and selling Aurinia Pharmaceuticals Inc stock.
The insider traders at Aurinia Pharmaceuticals Inc are: Michael Robert Martin, Robert Bindert Huizinga, Joseph M Miller, Peter Greenleaf, Jill Leversage, Stephen P Robertson, Greg Keenan, Matthew Maxwell Donley, Neil Solomons, David R.W. Jayne, Jeffrey Allen Bailey, George M Milne Jr, Scott Michael Habig, and Joseph P Hagan
The most active insider trader at Aurinia Pharmaceuticals Inc is Michael Robert Martin with 8 trades.
Robert Bindert Huizinga has sold the most Aurinia Pharmaceuticals Inc stock with a total value of $9,202,050.00.
George M Milne Jr has bought the most Aurinia Pharmaceuticals Inc stock with a total value of $356,400.00.
The most recent insider trade for Aurinia Pharmaceuticals Inc was on March 7, 2025.
The single biggest insider buy for Aurinia Pharmaceuticals Inc was from George M Milne Jr with a total value of $178,200.00 on March 2, 2023.
The single biggest insider sell for Aurinia Pharmaceuticals Inc was from Robert Bindert Huizinga with a total value of $3,867,500.00 on Oct. 25, 2021.